Tofacitib is Tofacitib citrate, the earliest two weeks after taking Tofacitib citrate can see the effect, but due to the individual and the degree of disease differences, the starting effect also exists differently, it is recommended that the patient to the actual situation prevail.
Tofacitib citrate is usually able to improve the patient’s physical function, reduce fatigue, relieve pain, improve sleep, etc. in as little as two weeks.
Tofacitib citrate is a new type of small molecule inhibitor with immunomodulatory effects, which can be used in the treatment of rheumatoid arthritis. Tofacitib citrate is used to treat rheumatoid arthritis by blocking the JAK-like signaling pathway. It has better efficacy in the treatment of rheumatoid arthritis.
Tofacitib citrate may cause patients to develop serious infections, blood clots, elevated liver enzymes and other adverse reactions.
The use of Tofacitib is prohibited in pregnant women, lactating women and patients who are allergic to the drug components.
Precautions: this product should be used with caution in patients with severe infectious diseases, malignant tumors, and a history of blood clots. It is not recommended to combine Tofacitib with biological DMARD drugs or potent immunosuppressants (such as azathioprine and cyclosporine).
It is recommended to use this product properly under the guidance of a doctor.